Skip to main content
Erschienen in: Hepatology International 1/2021

28.01.2021 | COVID-19 | Letter to the Editor Zur Zeit gratis

Chronic liver disease independently associated with COVID-19 severity: evidence based on adjusted effect estimates

verfasst von: Haiyan Yang, Jie Xu, Xuan Liang, Li Shi, Yadong Wang

Erschienen in: Hepatology International | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Recently, a meta-analysis by Kovalic et al. reported that chronic liver disease was significantly associated with severe coronavirus disease 2019 (COVID-19) and mortality [1]. This is an interesting study. However, the pooled effect on the association between chronic liver disease and severe COVID-19 was estimated based on un-adjusted effect sizes in Kovalic et al.’s study [1]. It has been considered that several factors such as gender, age and certain comorbidities significantly influenced COVID-19 outcomes [25]. This suggests that these factors might modulate the relationship between chronic liver disease and COVID-19 severity. Therefore, it is urgently required to clarify this association by performing a quantitative meta-analysis based on adjusted effect estimates. …
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kovalic AJ, Satapathy SK, Thuluvath PJ. Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis. Hep Intl 2020;14(5):612–20CrossRef Kovalic AJ, Satapathy SK, Thuluvath PJ. Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis. Hep Intl 2020;14(5):612–20CrossRef
2.
Zurück zum Zitat Liang X, Shi L, Wang Y, Xiao W, Duan G, Yang H, et al. The association of hypertension with the severity and mortality of COVID-19 patients: evidence based on adjusted effect estimates. J Infect 2020;81(3):e44–7CrossRef Liang X, Shi L, Wang Y, Xiao W, Duan G, Yang H, et al. The association of hypertension with the severity and mortality of COVID-19 patients: evidence based on adjusted effect estimates. J Infect 2020;81(3):e44–7CrossRef
3.
Zurück zum Zitat Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B. Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis. Intervirology 2020;9:1–12 Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B. Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis. Intervirology 2020;9:1–12
4.
Zurück zum Zitat Xu J, Xiao W, Liang X, Zhang P, Shi L, Wang Y, et al. The association of cerebrovascular disease with adverse outcomes in COVID-19 patients: a meta-analysis based on adjusted effect estimates. J Stroke Cerebrovasc Dis 2020;29(11):105283CrossRef Xu J, Xiao W, Liang X, Zhang P, Shi L, Wang Y, et al. The association of cerebrovascular disease with adverse outcomes in COVID-19 patients: a meta-analysis based on adjusted effect estimates. J Stroke Cerebrovasc Dis 2020;29(11):105283CrossRef
5.
Zurück zum Zitat Dorjee K, Kim H, Bonomo E, Dolma R. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: a comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients. PLoS One 2020;15(12):e0243191CrossRef Dorjee K, Kim H, Bonomo E, Dolma R. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: a comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients. PLoS One 2020;15(12):e0243191CrossRef
Metadaten
Titel
Chronic liver disease independently associated with COVID-19 severity: evidence based on adjusted effect estimates
verfasst von
Haiyan Yang
Jie Xu
Xuan Liang
Li Shi
Yadong Wang
Publikationsdatum
28.01.2021
Verlag
Springer India
Schlagwort
COVID-19
Erschienen in
Hepatology International / Ausgabe 1/2021
Print ISSN: 1936-0533
Elektronische ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-020-10133-y

Weitere Artikel der Ausgabe 1/2021

Hepatology International 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.